Mutagenesis of the dimer interface residues of tethered and untethered HIV-1 protease result in differential activity and suggest multiple mechanisms of compensation  by Choudhury, Sumana et al.
Mutagenesis of the dimer interface residues of tethered and untethered
HIV-1 protease result in differential activity and suggest multiple
mechanisms of compensation
Sumana Choudhury,a Lori Everitt,a Steven C. Pettit,a and Andrew H. Kaplana,b,c,d,*
a Department of Medicine, UNC School of Medicine, Chapel Hill, NC 27599, USA
b Department of Microbiology & Immunology, UNC School of Medicine, Chapel Hill, NC 27599, USA
c Lineberger Comprehensive Cancer Center, UNC School of Medicine, Chapel Hill, NC 27599, USA
d Center for Infectious Diseases, UNC School of Medicine, Chapel Hill, NC 27599, USA
Received 25 February 2002; returned to author for revision 10 May 2002; accepted 18 July 2002
Abstract
As is the case for all retroviruses, the protease of HIV-1 is only functional as a homodimer; dimerization of two protease monomers
results in the formation of the enzyme active site. This dimer structure is supported primarily by interactions between the first four
amino-terminal and the last four carboxy-terminal amino acids. These eight amino acids form a -sheet in which hydrophobic residues are
oriented towards the core of the molecule and polar residues are directed towards the solvent. Although the structure of the dimer interface
has been determined, the forces that support dimerization have not been fully characterized. Here, we describe a tethered construct in which
two protease monomers are joined by a 5 amino acid linker. We evaluate the relative role of each dimer interface residue in functional homo-
and heterodimers. Our studies indicate that the hydrophobic residues of the dimer interface are particularly important in maintaining enzyme
activity and that enzyme activity is more sensitive to substitutions of the C-terminal amino acids. Further, we demonstrate that the presence
of the tether is able to compensate for mutations within the dimer interface that inactivate the enzyme.
© 2003 Elsevier Science (USA). All rights reserved.
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Introduction
Dimerization of the HIV-1 protease is an essential step in
viral replication. Enzyme activity requires the formation of
protease homodimers (Wlodawer et al., 1989). Mutations
that block dimerization interfere with protease function;
viral variants encoding non-functional enzymes are aber-
rantly assembled and are non-infectious (Kaplan et al.,
1993; McPhee et al., 1996; Schramm et al., 1993; Zhang et
al., 1991).
Crystallographic studies demonstrate that the protease
monomers are joined by a total of 34 hydrogen bonds and 4
salt bridges and half of these interactions occur in a region
known as the dimer interface (Wlodawer et al., 1989). The
dimer interface is comprised of eight interdigitating N- and
C-terminal residues on each of the two monomers (residues
1–4 and residues 96–99) in a four-stranded -sheet arrange-
ment that orients the polar side chains of Q2, T4, T96 and
N98 towards solvent. The side chains of P1, I3, L97 and F99
are oriented toward the body of the enzyme and are in-
volved in hydrophobic interactions (Fig. 1). C-terminal res-
idues 96–99 are predicted to be particularly important in
dimer formation as they contribute roughly 50% of the
inter-subunit ionic and H-bond interactions and 45% of the
buried surface area during dimer formation (Weber, 1990).
Dimerization results in the formation of an active site
pocket. The two catalytic aspartic acids are located in the
floor of the pocket and the roof is formed by two flexible
flaps that close over the active site (Navia et al., 1989;
Wlodawer et al., 1989).
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Little is known about the individual contributions of
dimer interface residues in maintaining enzyme activity.
Residues 1–4 and 96–99 are conserved between different
HIV-1 isolates. However, there is considerable variation in
the sequence of the dimer interface between divergent ret-
roviruses (Blundell et al., 1991; Weber, 1989) despite con-
servation of the 4 stranded -sheet structure (Gustchina et
al., 1996; Rose et al., 1993b; Vondrasek et al., 1997; Weber,
1990). This observation suggests that a large degree of
sequence variation is allowed without disrupting overall
structure and activity.
Previous mutational analyses of the HIV-1 dimer inter-
face have been limited in selection and have been primarily
restricted to extended protease forms that use protease ac-
tivation and self processing as a measure of activity. Loeb et
al. (1989) found that dimer interface mutations evaluated in
the context of a Pol precursor were relatively insensitive to
non-conservative substitution with the exception of Q2, L97
and F99 position.
Since the functional enzyme is a homodimer, any sub-
stitution introduced into the protease coding domain will be
present in both monomers symmetrically. A number of
groups have produced “tethered” dimers of the HIV-1 pro-
tease in which two monomers are joined C-terminus to
N-terminus by a flexible linker of 2–5 amino acids (Babe et
al., 1992; Bhat et al., 1995; Cheng et al., 1990; Dilanni et
al., 1990; Krausslich, 1991; Krausslich, 1992; Panchal and
Hosur, 2000; Tozser et al., 1997). This “head-to-tail” ar-
rangement is based on crystal structures of the native, two-
chain dimers which demonstrate that the N- and C-termini
of different subunits are located within a few Å of each
other. It has been shown that tethered dimers have a wild-
type substrate specificity (Bhat et al., 1994; Cheng et al.,
1990; Griffiths et al., 1994; Phylip et al., 1995). Crystallo-
graphic studies demonstrate that the structure of the single
chain dimers is nearly identical to the native, two-chain
protease (Bhat et al., 1994; Bhat et al., 1995).
The evaluation of these tethered constructs has furthered
our understanding of the relative contribution of each half of
the functional enzyme to enzyme structure and function.
However, the biochemical assays required to assay enzyme
activity are relatively cumbersome and not particularly well
Fig. 1. Stick model of the antiparallel -sheet arrangement of the dimer interface of HIV-1 protease. Based on the crystal structure of Erickson et al. (1990).
Nitrogens are shown as blue; oxygens as red. The side chains of polar residues Q2, T4, T96, and N98 extend into solution; hydrophobic residues P1, I3, L97,
and F99 extend away from the viewer towards the body of the enzyme.
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suited to the rapid assessment of large numbers of mutants.
As part of our evaluation of protease dimer formation, we
have modified an expression system that produces a mono-
meric or single-chain tethered dimers of the protease to-
gether with a heterologous -galactosidase substrate altered
by the insertion of an HIV-1 protease cleavage site (Baum
et al., 1990). This system provides us with a color screen
with which we can rapidly evaluate the phenotype of mu-
tations introduced asymmetrically into one or the other
subunit of the dimer. Further, using a monoclonal antibody
specific for -galactosidase, we can estimate the relative
activity of these mutations by quantitative Western blot.
Our data identify the contribution of individual residues
within the dimer interface important for maintaining en-
zyme activity and suggest important roles for hydrophobic
and C-terminal residues of the dimer interface. In addition,
our results show that the deleterious effects of mutations
within the dimer interface can be compensated by multiple
mechanisms. These mechanisms include the presence of the
tether, the presence of a wild type monomer, and by second-
site phenotypic reversion.
Results
Alanine substitution of each dimer interface residue
results in a differental effect on enzyme activity
Baum et al. (1990) have described a system in which
monomers of the HIV-1 protease are co-expressed in E. coli
with -galactosidase modified by the addition of an HIV-1
protease cleavage site (Fig. 2). These studies demonstrate
that expressed monomeric protease undergoes dimerization
to cleave a heterologous -galactosidase substrate modified
by the inclusion of an HIV-1 processing site (Baum et al.,
1990). The -galactosidase substrate provides a convenient
color screen and a quantitative assay that allows us to
evaluate the phenotype of a mutated enzyme. We began our
characterization of the role of interface residues in enzyme
activity by alanine scanning mutagenesis of the untethered
homodimer. As expected, expression of wild-type HIV-1
protease in E. coli produced white colonies and fully
cleaved -galactosidase (107 kDa product), whereas blue
colonies and full-length -galactosidase (123 kDa product)
resulted from the expression of a protease containing an
active site D25N substitution (Fig. 3). Using independent
expressions of wild-type or mutant protease, we determined
that values derived by quantitative Western blot was repro-
ducible with a standard deviation of no more than 5%
cleavage and that the amount of error was independent of
the extent of -galactosidase cleavage (data not shown).
Next we replaced each of the dimer interface residues
individually with alanine and assayed the activity of each of
the mutants in E. coli. The transition from blue to white
colonies corresponded to roughly 40–50% cleavage of
Fig. 2. Schematic of pMono and pTether expression constructs. In both constructs, -galactosidase containing an inserted HIV-1 protease cleavage site is
expressed from the constitutive gpt promoter (Baum et al., 1990). Monomeric protease in pMono is expressed from the tac promoter. In pTether, the two
protease subunits are expressed as a single chain linked by a 5 residue tether (GTSSG) from the lac promoter.
Fig. 3. The effect of single alanine substitutions in the dimer interface of
untethered homodimeric protease (pMono) on the cleavage of the -ga-
lactosidase substrate. Lysates from E. coli 1061 expressing wild-type (WT)
or mutated protease were probed with anti--galactosidase antibody as
described in Materials and methods. Expression of protease carrying an
inactivating D25N substitution of the catalytic aspartate resulted in full
length uncleaved 123 kDa -galactosidase (upper band). Expression of
fully active wild-type (WT) protease produced 107 kDa cleaved -galac-
tosidase (lower band). The percent cleavage of -galactosidase substrate
estimated by quantitative Western blot is shown below each lane.
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-galactosidase as determined by Western blot (Table 1).
Alanine substitution of P1, Q2, and T4 resulted in activity
near wild-type levels (Fig. 3). However, the substitution of
alanine for I3, T96, L97, and F99 resulted in limited cleav-
age of -galactosidase as demonstrated by blue bacterial
colonies and the persistence of uncleaved -galactosidase
(Table 1 and Fig. 3). Substitutions for N98 were interme-
diate in phenotype; alanine and aspartic acid substitutions
resulted in 68% and 12% cleavage respectively (Table 1).
This result indicates that substitutions of individual side
chains in the dimer interface can have a dramatic detrimen-
tal effect on enzyme activity. The effect of alanine substi-
tution on activity was position dependent; many positions
tolerated substitution with little loss of activity. Generally,
residues on the amino terminal strand, with the exception of
I3, were less sensitive to substitution than residues on the
C-terminal strand.
We generated double alanine substitutions to examine
the relative importance of the N- and C-terminal strands of
the dimer. These substitutions placed an alanine on both the
hydrophobic and polar side of the interface (Fig. 1). Paired
alanine substitution of 2 and 3, 3 and 4, 96 and 97, and 97
and 98 resulted in profound effects on enzyme function. For
each of these strand-specific double substitutions, no detect-
able cleavage of -galactosidase was observed (Table 1).
This result suggests that while the amino terminal strand is
tolerant of single alanine substitutions in 3 of the 4 posi-
tions, both N- terminal and C-terminal strands are necessary
for protease activity.
Compensation of detrimental interface mutations in the
tethered enzyme
We extended our evaluation of dimer interface mutations
to the single chain tethered dimer. The plasmid pTether
expresses protease with the two subunits linked by a 5
amino acid tether (Fig. 2). To assess the activity of the
tethered dimer, we expressed the wild-type tethered con-
struct (wt/wt) together with the modified -galactosidase.
White colonies and near complete cleavage of -galactosi-
dase (107 kDa cleavage product) was observed by Western
analysis, thus demonstrating enzymatic activity of the single
chain tethered form of protease (Fig. 4A).
We next compared the effect of the alanine substitution
on enzyme activity when expressed as monomeric protease
or as a single chain tethered protease. As shown in Table 1,
many of the substitutions showed increased activity when
expressed in the tethered dimer. The amount of increase in
activity was position dependent, with I3A and N98D show-
ing the largest amount of increase. In general, interface
substitutions that had the greatest effect on activity when
expressed as untethered protease maintained a larger effect
when expressed as tethered. Several of the substitutions that
displayed no activity when expressed in monomeric form
had recovered measurable activity when expressed as a
single chain form (e.g., L97A, F99A, and all 4 double
substitutions, Table 1 and Fig. 4A). The presence of the
tether did not significantly reduce activity in any of the
mutations tested. These data indicate that a tether alone can
compensate in a position dependent manner for the detri-
mental effect of dimer interface mutations. In contrast, sub-
stitution of the active site catalytic aspartate (D25N/D25N)
showed no compensating effect from the tether (Table 1).
Finally, to assess whether the length of the tether effects
the amount of compensation we evaluated several of the
mutations in a construct in which the tether was lengthened
from 5 to 25 amino acids. Our results showed that the longer
tether is still able to compensate the effects of substitutions
in the dimer to the same degree as the shorter tether (data
not shown).
Table 1
Effect of the tether on the cleavage of -galactosidase and color screen analysis in homodimeric protease
Mutation Monomeric Tethered
% Cleavage* Std dev Color screen % Cleavage* Std dev Color screen
WT/WT 99% 2.0 white 95% 2.6 white
D25N/D25N 0% 0.0 blue 0% 0.0 blue
1A/1A 98% 4.0 white 91% 3.9 white
2A/2A 99% 2.0 white 90% 3.0 white
3A/3A 0% 0.0 blue 65% 4.8 white
4A/4A 99% 2.0 white 92% 1.4 white
96A/96A 14% 1.3 blue 85% 3.8 white
97A/97A 0% 0.0 blue 10% 7.2 blue
98A/98A 60% 7.9 white 87% 4.6 white
98D/98D 12% 7.0 blue 91% 5.1 white
99A/99A 0% 0.0 blue 37% 10.8 blue
2A3A/2A3A 0% 0.0 blue 45% 8.0 b/w
3A4A/3A4A 0% 0.0 blue 22% 7.0 blue
96A97A/96A97A 0% 0.0 blue 11% 8.6 blue
97A98A/97A98A 0% 0.0 blue 12% 8.1 blue
* Mean of 4–5 replicates.
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A wild type subunit in one half of the tethered protease
can compensate for mutations in the dimer interface
Previous mutational analyses of the HIV protease dimer
interface residues have been limited to an evaluation of the
homodimeric enzyme. Although these studies have demon-
strated that these residues are important for enzyme func-
tion, the phenotype of each mutant enzyme reflected the
presence of a double, identical substitution in each subunit.
Therefore, to characterize the contribution of individual
dimer interface residues to enzyme activity, we introduced
substitutions in only one subunit of the tethered dimer.
We found that the presence of a wild-type monomer
compensated to some degree for every interface mutation
tested (Table 2, compare Fig. 4A to Fig. 4B). However, the
amount of compensation by the wild-type subunit varied
with position. Single alanine substitutions for L97 and F99
showed the largest degree of compensation (10% to 80%,
34% to 88% cleavage respectively) (Table 2). In general all
of the dimer interface mutations tested were able to recover
activity to at least 70% cleavage of -galactosidase when
linked to a wild-type monomer. Thus, the compensation of
detrimental interface mutation by a wild-type subunit was
additive to the compensating effect of the tether. The most
dramatic compensation was seen in the L97A and F99A
mutations which were inactive when expressed in monomer
form, but recovered activity to 80% and 88% cleavage of
-galactosidase when expressed alone in the tethered en-
zyme (compare Tables 1 and 2). Although we observed
compensation of all dimer interface mutations we tested by
a wild-type subunit, we observed no compensation of the
catalytic D25N mutation. This observation is in agreement
with previous studies of enzyme catalysis that two catalytic
aspartates are required for enzymatic activity (Dilanni et al.,
1990; Jaskolski et al., 1991)
We also examined whether there was position depen-
dence to the placement of the wild-type subunit within the
single chain protease. We reversed the order of mutated and
wild-type subunits within the tethered protease in the 2A3A,
3A4A, 96A97A, and 97A98A mutations and compared ac-
tivity (data not shown). We found that the degree of com-
pensation was similar whether the mutation was place first
or second subunit. This result indicated that the compensat-
ing effect of the wild-type subunit is independent of the
position of the subunit.
Second site substitutions within the same subunit can
compensate for deleterious interface mutations
These data suggest that a tethered dimer can retain func-
tion if the dimer interface of just one of the subunits is
intact, even if the other subunit contains destabilizing sub-
stitutions in dimer interface residues. Although the presence
of wild-type dimer interface residues on one subunit may
rescue enzyme function, the mechanism by which this is
accomplished is unclear. For example, it is uncertain
whether specific side chain interactions between the two
monomers are required to maintain enzyme activity or if
any properly folded monomer in one position will compen-
sate for an inactivating mutation in the opposite dimer
interface.
To characterize the interaction between the dimer inter-
face residues on the two subunits further, we attempted to
identify compensatory substitutions that are capable of re-
storing enzyme activity. Previously, we had determined that
a substitution of Gln to Pro at position 2 partially restores
the enzyme activity that is lost when the Asn at position 98
is replaced by an Asp (data not shown). A tethered dimer
containing the N98D substitution on one subunit and the
96A97A substitution on the other subunit decreased the
percentage cleavage of -galactosidase from 94% to 34%
(Fig. 5). However, when the second-site Q2P substitution
was added to the subunit containing the N98D mutation,
much of the activity of the heterodimer was restored (Fig. 5,
Fig. 4. The effect of interface mutations placed doubly in both subunits or
singularly in the 2nd subunit on the activity of tethered protease. Tethered
protease was expressed with the -galactosidase substrate in E. coli
MC1061 and probed by Western blot with an anti--galactosidase anti-
body. A wild-type subunit is designated Wt. The D25N substitution is a
mutant of the catalytic aspartate residue. The percentage of cleaved -ga-
lactosidase substrate is shown below. A. The effect of expressing mutations
as a tethered homodimer. B. The effect of the same mutations as a tethered
heterodimer with a wild-type (Wt) second monomer.
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compare lanes 5 and 6). Thus, the Q2P N98D combination
in one tethered protease subunit was able to increase activity
of the N98D/ 96A 97A mutant.
Discussion
Several structural analyses have suggested that the resi-
dues of the dimer interface play a critical role in maintaining
the HIV protease dimer structure. We have extended these
studies by comparing the activity of untethered dimers con-
taining symmetric mutations and tethered dimers containing
symmetric and asymmetric dimer interface substitutions.
Further, we have adapted a bacterial expression system that
allows us to screen large numbers of substituted enzymes
rapidly and then assess the relative ability of these mutants
to cleave an indicator protein. This approach provides new
insights into the mechanism and control of protease dimer-
ization.
Our alanine substitution studies of the monomeric pro-
tease suggest that allowed side chain substitutions are po-
sition dependent within the 8 residues of the dimer interface.
Generally, we found that substitution of the hydrophobic
residues (I3, L97, F99) produced a greater decrease in
activity than the polar residues (Q2, T4, N98). This supports
previous suggestions that hydrophobic packing forces play a
major role in protease dimerization (Weber, 1990). The
polar residues Q2 and N98 have been proposed by structural
studies to form interstrand hydrogen bond pairs in the dimer
interface (Weber, 1990; Wlodawer et al., 1989). Our results
suggest that the hydrogen bonding of polar residues is a
minor contribution to dimerization. The position dependent
effects of single alanine substitutions reported here corre-
spond well to the energetic contribution of the single resi-
dues previously determined by Todd et al. (1998). In par-
ticular, Todd et al. indicated that Q2 and T4 provide less
Gibbs free energy towards dimerization than other residues
of the dimer interface.
We also observed that the C-terminal residues were gen-
erally less tolerant of substitution than the N- terminal
residues. This finding is in agreement with Weber et al.
(1990), who suggested that the C-terminal strand contrib-
utes more to dimerization than the amino terminal strand.
However, we also find that particular mutations of both
strands are able to inhibit enzyme activity completely. Oth-
ers have found that the amino terminal strand is necessary
for enzyme activity. In these studies, deletion of residues
1–5 (Babe et al., 1991) or removal of the same by autolysis
(Mildner et al., 1994; Rose et al., 1993a) resulted in an
enzyme that was inactive, yet still capable of exerting a
trans-dominant negative effect. The conclusion that a func-
Table 2
Rescue of inactivating mutations by a WT monomer in the tethered protease
Homodimer Heterodimer
Mutation % Cleavage* Std dev Color screen Mutation % Cleavage Std dev Color screen
WT/WT 95% 2.6 white WT/WT 95% 2.6 white
D25N/D25N 0% 0.0 blue D25N/WT 0% 0.0 blue
1A/1A 91% 3.9 white 1A/WT 93% 2.6 white
2A/2A 90% 3.0 white 2A/WT 92% 2.9 white
3A/3A 65% 4.8 white 3A/WT 77% 3.0 white
4A/4A 92% 1.4 white 4A/WT 95% 4.4 white
96A/96A 85% 3.8 white 96A/WT 92% 2.5 white
97A/97A 10% 7.2 blue 97A/WT 80% 4.1 white
98A/98A 87% 4.6 white 98A/WT 95% 4.1 white
98D/98D 91% 5.1 white 98D/WT 93% 5.6 white
99A/99A 37% 10.8 blue 99A/WT 86% 3.1 white
2A3A/2A3A 45% 8.0 b/w 2A3A/WT 83% 5.1 white
3A4A/3A4A 22% 7.0 blue 3A4A/WT 75% 4.0 white
96A97A/96A97A 11% 8.6 blue 96A97A/WT 64% 6.9 white
97A98A/97A98A 12% 8.1 blue 97A98A/WT 82% 5.3 white
* Mean of 4–5 replicates.
Fig. 5. Increase in activity in tethered N98D/T96A L97A protease by a
second site Q2P substitution. Western blot analysis with anti--galactosi-
dase antibody is shown. The percent cleavage of the -galactosidase
substrate is shown below.
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tional amino terminal strand is necessary for enzyme func-
tion conflicts with the intramolecular processing model pro-
posed by others for the cleavage of the TF/PR site (Co et al.,
1994; Louis et al., 1999; Louis et al., 1994; Navia et al.,
1989). Our results suggest that dissociation of the amino
terminal strand to act as a cis-acting substrate would pro-
duce an inactive enzyme. Nevertheless, our observations
support previous structural and biochemical analyses of the
wild-type tethered protease dimer and suggest that the rel-
ative significance of each of the dimer interface residues is
maintained, although to a less degree, when the two sub-
units are held together by the tether.
It seems likely that the tether would promote the forma-
tion of a stable dimer by increasing the local concentration
of each of the subunits. Our observation that the presence of
a tether can compensate for mutations in the enzyme dimer
interface supports this reasoning. The compensating effect
appears specific to dimer interface mutations since tethered
enzymes containing mutations that inactivate one of the
active site aspartic acids or interfere with the motion of the
enzyme flap on one of the subunits (Tozser et al., 1997)
remain inactive in tethered form. In the virus, protease is
translated as part of the GagPol precursor (Jacks et al.,
1988); thus it is possible that the multimerization of GagPol
molecules during virion assembly function to promote
dimerization by a mechanism analogous to that of the tether.
Others have noted previously that the presence of the tether
can promote enzyme stability and dimerization (Cheng et
al., 1990; Dilanni et al., 1990), although these studies were
performed only on wild-type protease.
One limitation of our evaluation of the effect of dimer-
ization mutants is that our assessment of phenotypes is
limited to enzyme activity measurement rather than the
actual dissociation of the enzyme. The observation that all
detrimental dimer interface mutations tested showed a mea-
surable increase in activity when expressed in tethered form,
while the catalytic D25N substitution showed no increase,
suggests that dimer interface mutations tested affect dimer-
ization. However, we can not rule out that particular muta-
tions affect catalytic activity as well. One possible example
is found in L97 that makes a hydrophobic interaction with
T26 neighboring the catalytic aspartate, D25.
Thus, disruption of activity observed with the L97A
mutation and others may have a catalytic component as
well.
The observations reported here suggest several conclu-
sions. First, in all cases tested, tethered enzymes in which a
single subunit contains inactivating mutations in dimer in-
terface residues are functional. Therefore, it seems unlikely
that these dimer interface substitutions produce unintended
major perturbations in the enzyme active site. Second, the
ability of the tether to compensate for mutations that disrupt
the dimer interface also indicates that whether the enzyme
active site is formed as a result of interactions at the dimer
interface or through the action of the tether, the protease
retains its function. Finally, our data also demonstrate com-
pensation of deleterious dimer interface mutations can occur
by multiple, additive mechanisms.
Materials and methods
Plasmid construction and mutagenesis
Plasmid pMono, which expresses mutant or wild-type
monomeric protease under control of the tac promoter, was
constructed from the plasmid PI  IQ (Baum et al., 1990)
as follows: The protease coding domain downstream of the
tac promoter was deleted by inverse PCR. A linker consist-
ing of 5 XhoI-XbaI-SalI-PstI 3 was inserted to produce
p1CVx. Mutant or wild type protease sequences were ob-
tained by PCR of pET-PR by primers 5Xho (AATATA-
XhoI-GAAGGAGATATACAT and 3Xba (ATAAAT-
XbaI-CTTGGGCTGCAGGG) and inserted into p1CVx to
produce pMono. The plasmid pET-PR contains the 99 res-
idue coding domain of monomeric protease HXB2 isolate
(Ratner et al., 1987) inserted behind an initiating methionine
into the NdeI-BamHI sites of pET24a (Novagen).
Plasmid pTether was constructed by insertion of a com-
plimentary oligonucleotide linker encoding 5 XhoI-Gly-
Thr-Ser-Ser-Ser-XbaI 3 into the XhoI-XbaI site of p1CVx
to create p1CVspe. The linker contained a unique SpeI site
overlapping the codons for Gly-Thr for insertion of the 1st
and 2nd protease monomers. Wild-type or mutant protease
sequences encoding the first protease monomer were ob-
tained from pET-PR by PCR with primers 5Xho and 3Spe
(5AATATA-SpeI-ACCAAAAATTAAAGTGCAACC).
Insertion of the 1st monomer sequences into p1CVspe cre-
ated pPR1spe. Insertion of the 2nd protease domain into
pPR1spe was performed by PCR of pET-PR with primers
5Spe (TATTAT-SpeI-TCTGGGCCTCAGATCACTCTT-
TGG) and 3Xba.
To limit cell toxicity, the tac promoter (de Boer et al.,
1983) in pTether was mutated to a wild-type lac promoter
by substitution of positions within the35 and10 regions
as follows: 35: TTGACA to TTTACA, 10: TATAATG
to TATGTTG. Mutagenesis was performed on the p1CVx
parental plasmid by the QuikChange mutagenesis protocol
according to the directions of the manufacturer (Stratagene).
pTether25 was constructed by insertion of complimentary
oligonucleotides encoding four additional translationally-
optimized (CUTG-Codon Usage Tabulated from Genbank)
repeats of Gly-Thr-Ser-Ser-Gly into the SpeI site of
pTether.
Mutagenesis of the protease coding domain in pET-PR
was performed as previously described using uracil-substi-
tuted single-stranded templates (Bebenek and Kunkel,
1989; Kunkel, et al., 1991). Mutations were confirmed by
DNA sequencing prior to transfer of the protease sequences
in pMono or pTether constructs. For construction of a li-
brary of possible 2nd site mutations in the pTether 98D/
96A97A construct, site-directed mutagenesis was per-
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formed as described above on pETPR 98D with random
oligonucleotides degenerate for either the Q2, I3, or T4
codons prior to insertion of the first monomer into pTether
WT/96A97A. Possible phenotypic revertants were screened
for the presence of light blue or white color on X-gal
indicator plates as described below. Following screening,
the presence of a 2nd site mutation was confirmed by
sequencing prior to Western blot determination of the per-
cent of -galactosidase cleaved (described below).
Colony color-screen analysis for -galactosidase activity
The plasmid pMono or pTether was transformed into E.
coli MC1061 cells and plated on LB with 100 g/ml am-
picillin. Colonies were replica plated onto LB supplemented
with 100 g/ml ampicillin, 100 g/ml X-gal, and either 100
g/ml isopropyl -D-thiogalactopyranoside (IPTG) (pMono)
or 30 g/ml IPTG (pTether). Replica plates were incubated
at 37°C for 2–3 h until color developed.
Western blot determination of the percent
of -galactosidase cleavage
Samples for Western blot analysis were collected from
uninduced mid-log (OD600 0.5) cultures of E. coli strain
MC1061 carrying either pMono or pTether grown in YT
media. Cells were pelleted and resuspended in 400 l X
(OD600) of SDS–PAGE sample buffer (Pettit et al., 1991)
heated to 95°C for 4 min, and clarified by centrifugation.
SDS polyacrylaminde gel electrophoresis (SDS–PAGE)
was performed on standard 7.5% Laemmli gels (Laemmli,
1970). Separated proteins were transferred to nitrocellulose
by electroblot, blocked for 1 h with 3% bovine serum
albumin in Tris buffered saline–0.1% Tween 20 (TBS-tw)
(10 mM Tris pH 8.0, 8% w/v NaCL) and probed by anti-
-galactosidase monoclonal antibody (Boehringer) at a
1:5000 dilution. Following subsequent washes in TBS-tw,
-galactosidase was detected with the ECL Plus system
followed by autoradiography according to the instructions
of the manufacturer (Amersham Pharmacia).
Densitometric analysis of the cleavage of -galactosi-
dase was performed by placing blots directly on a Molecular
Dynamics Storm model 800 phosphoimager. For scanning,
the phosphoimager was set in blue fluorescence/chemifluo-
rescence mode at a PMT voltage of 700 V. Determination of
the final value for the percent cleavage of the -galactosi-
dase substrate was determined by taking the average value
of 2 or more independent inductions. We found that the
value of the percentage of -galactosidase cleavage varied
by 5% cleavage or less between duplicate inductions in the
Western blot and that the amount of variation was indepen-
dent of the extent of -galactosidase cleavage (data not
shown).
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